Sched.com Conference Mobile Apps
DIA 2025 Global Annual Meeting
DIA 2025 Global Annual Meeting
Sign up
or
log in
to bookmark your favorites and sync them to your phone or calendar.
Schedule
Speakers
Search
Menu
Schedule
Speakers
Search
Ciby Abraham
AstraZeneca, United States
Senior Director and Group Manager, Project and Product Leadership
Maria Paula Bautista Acelas
DIA, United States
Senior Scientific Project Manager
Sarah Adam
IFPMA, Switzerland
Associate Director, Regulatory Affairs
EA
Eishita Agarwal
GSK, India
Digital Innovation Manager, Medical Writing
MA
Michael Ageboh
Pharmalex / Cencora, United States
Senior Manager, Medical Device/IVD
MA
Meha Ahmed
FDA, United States
ORISE FELLOW
ZA
Zinah Alabdulkarim
SFDA, Saudi Arabia
Senior Scientific Evaluation Expert
AA
Abdulaziz Alageel
Saudi Food and Drug Authority, Saudi Arabia
Senior Alert and Monitoring Expert
Rita Algorri
Amgen, United States
Senior Manager, Global Regulatory Affairs (CMC)
Jeff Allen
Friends of Cancer Research, United States
President and Chief Executive Officer
SA
Saeed Alshahrani
Saudi Food & Drug Authority, Saudi Arabia
Alarm & Control Expert
Maria Amaya
Genentech, A Member of the Roche Group, United States
Lead External Advocacy, North America
VA
Vasanti Anand
BMS, United States
Regulatory Writer
Hillary Andrews
Friends of Cancer Research, United States
Director, Regulatory and Research Partnerships
Artem Andrianov
Cyntegrity Germany GmbH, Germany
CEO
JA
Julieta Argüelles
MD Anderson Cancer Center, United States
Researcher
Barbara Isquith Arone
IQVIA, United States
Vice President, Evidence Generation for Medical Affairs
Troy Astorino
PicnicHealth, United States
CTO
Susanne Ausborn
Roche, Switzerland
Global Head International Regulatory Policy
Kassa Ayalew
FDA, United States
Director, DCCE, OSI, Office of Compliance, CDER
NA
Nicolai Ayasse
Critical Path Institute, United States
Clinical Outcome Assessment Scientist
MB
Maria Baier
Boehringer Ingelheim Pharma Gmbh & Co. KG, Germany
Data Scientist
Rosalyn Bailey
Syneos Health, United States
Executive Director NA & LATAM Head – Global Regulatory Affairs...
Junaid Bajwa
Pioneering Intelligence, United Kingdom
Senior Partner, Head of UK, and Science Partner, Pioneering...
DB
Denyse Baker
Eli Lilly and Company, United States
Assoc. Vice President Global Quality Compliance
Venkatraman Balasubramanian
VB Insights, LLC, United States
Healthcare and Life Sciences Strategic Advisor
Greg Ball
ASAPprocess, United States
Safety Data Scientist
Simge Baloglu
Bluerock Therapeutics, United States
SVP Analytical and Quality Control
Khaudeja Bano
Genentech, United States
Vice President, Combination Product Quality
SB
Szczepan Baran
Chief Barks and Purrs Officer, United States
Tech4Pets
LB
Leo Barella
Takeda, United States
Chief Technology Officer
SB
Shelly Barnes
UCB, United States
Global Clinical Innovations Lead
Tajuana Barron
PCM Trials, United States
Vice President Project Management Global Clinical Trials
Andrew Bate
GlaxoSmithKline, United Kingdom
Vice President, Head of Safety Innovation and Analytics
Maree Beare
Clinials, Australia
Founder and CEO
CB
Clare Bedford
DIA, United States
Member Engagement & Operations Manager
Emmanuel Belabe
ArisGlobal, United States
Senior Global Head, Operational Excellence
Rachel Belani-Barker
Syneos Health Consulting, United States
Managing Director
AB
Andrea Bell-Vlasov
U.S. Food & Drug Administration, United States
Science Policy Analyst
Simon Bennett
Biogen, United Kingdom
Director, EU Regulatory Policy
Robyn Bent
FDA, United States
Director, Patient Focused Drug Development, OCD, CDER
SB
Stephane Berard
Health Canada, Canada
Interim Supervisor-Health Product Compliance East Unit
Cedric Berger
F. Hoffmann-La Roche, Switzerland
Head of Knowledge Extraction and Integration
SB
Saba Berhane
IFPMA, Switzerland
Manager, Regulatory Affairs
Janis Bernat
IFPMA, Switzerland
Director, Scientific and Regulatory Affairs
Amy Bertha
Bayer, United States
Executive Director, Regulatory Policy and Science
James Bertram
FDA, United States
Director, Office of Combination Products, OC
Sanghita Bhattacharya
Johnson & Johnson Innovative Medicine, United States
Director Data Science Global Function
Katie Bloom
Ultragenyx, United States
Executive Director, Co-Head of PMO, Program Management Office
WB
William Blumentals
Sanofi, United States
Head of Pharmacoepidemiology, Special Care
Anna Bode
Kearney, Germany
Principal
TB
Thomas Bognanno
Alliance Practice, United States
Patient Representative
Paul Bolot
Bayer Consumer Care AG, Switzerland
Global Regulatory Strategist
David Borasky
WCG IRB, United States
Vice President, IRB Compliance
MB
Marcin Boruk
Health Canada, Canada
Manager RMOD, HFPB
Jaclyn Bosco
IQVIA, United States
Vice President & General Manager, Global Head of Epidemiology...
Amanda Kirby Bowles
Deloitte, United States
Managing Director
Donna Boyce
Pfizer Inc, United States
Head and Senior Vice President of Global Regulatory Sciences
Brian Bradbury
Amgen, United States
Vice President, Center for Observational Research
Chris Bray
Merck Serono Ltd., United Kingdom
Head of Global Regulatory Affairs Precision Medicine & Companion...
Denise Bronner
Empactful Ventures, United States
Founder & CEO
Nick Brown
Certara, United States
Director, Global Portfolio Leader, Certara.AI
Sharon Brown-Singleton
MedNorth Health Center, United States
Chief Strategy Officer
James Browning
Amgen, United States
Director of Biostatistical Programming, Center for Observational...
Mandy Budwal-Jagait
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GCP
Kevin Bugin
Amgen, United States
Head of Global Regulatory Policy and Intelligence
Huwaida Bulhan
Roche Kenya Limited, Kenya
Senior Clinical Research Operations Lead Area Africa
Namandjé Bumpus
Bumpus Advising, United States
Founding Principal
Mehmet Burcu
Merck & Co., Inc., United States
Senior Director, Epidemiology
Amanda Burkhardt
University of Southern California, United States
Assistant Professor, Alfred E. Mann School of Pharmacy and Pharma...
Brendan Burns
Mersana Therapeutics, United States
Manager, Document Control & Training
AB
Andrew Byrnes
FDA CBER, United States
Director, Division of Gene Therapy 1
Bill Byrom
Signant Health , United Kingdom
Vice President, Product Intelligence and Positioning; Principal, eCOA...
David Campard
Novo Nordisk A/S, Denmark
CMC RA Specialist
Ulka Campbell
Aetion Inc, United States
Head of Scientific Strategy
EC
Eleanor Caplan
Johnson & Johnson Innovative Medicine, United States
Senior Principal Scientist
Emily Carter
AbbVie, United States
Director, Data Science & Analytics
Brooke Casselberry
Epista Life Sciences, United States
Vice President, Advisory and Delivery
Alison Cave
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Chief Safety Officer
JC
June Cha
Milken Institute, United States
Policy Director, FasterCures
James Chambers
Tufts Medical Center, United States
Associate Professor, Institute for Clinical Research and Health...
Joan Chambers
Tufts CSDD, United States
Senior Consultant
Ankush Chandna
ZS Associates , United States
Data Science Lead, Research and Development Excellence
Andrew Chang
Novo Nordisk, United States
Vice President, Quality and Regulatory Compliance
SC
Shou-Bai Chao
CanSino Biologics Inc., China
Chief Operating Officer
MC
Maryann Chapin
Food and Drug Administration, United States
ORISE Fellow
Sharon Chen
AlphaLife Sciences, United States
Founder and CEO
Xianwen Chen
University of Macau, Macao
Student
Matthew Chervenak
Allsci, United States
Founder & CEO
JC
Joan Cheung
NNIT, United States
Senior Consultant
Karla Childers
Johnson & Johnson, United States
Head, Bioethics-Based Science and Technology Policy
Constance Chisha
University of the Witwatersrand, South Africa
PhD Student
Stephanie Choi
EMD Serono, United States
Director, US Global Regulatory and Scientific Policy (GRASP)
SC
Susan Chong
Amgen Inc., United States
Senior Manager, Global Regulatory Policy and Intelligence
AC
Ashar Choudhry
Bristol Myers Squibb, United States
Executive Director, Enterprise Operational Excellence
Andrew Ciupek
GO2 for Lung Cancer, United States
Associate Director, Clinical Research
R. Angelo De Claro
FDA, United States
Associate Director for Global Clinical Sciences, Oncology Center of...
Cal Collins
OpenClinica, LLC, United States
Chief Executive Officer
PC
Pamela Concepcion
Astrazeneca, United States
Patient Safety Scientist
Donna Libretti Cooke
ImpactSphere Clinical, LLC, United States
Chief Impact Officer & Owner
Torrey Cope
Sidley Austin LLP, United States
Partner
JC
Jhon Cores
Moderna, Inc, United States
Associate Director, Medical Writing
AC
Ana Corona
University of Utah, United States
Translator
Karen Correa
Boehringer Ingelheim, United States
Vice President, Clinical Development Operations
Solange Corriol-Rohou
AstraZeneca , France
Senior Director, Global Regulatory Affairs & Policy, R&D,...
Stephen Corson
Phastar, United Kingdom
Associate Director, Statistics and Technical Solutions
Catherine Coulouvrat
Sanofi, France
Head of Health Value Translation
Alysha Croker
Health Canada, Canada
Director of the Centre for Policy, Pediatrics and International...
Matthew Curin
Galderma, United States
Sr. Dir, Head of Program Management, Therapeutic Dermatology
Kavita Dada
FDA, United States
Associate Director of Regulatory Operations, OSI, OC, CDER
Lorraine Danks
Gates Foundation, South Africa
Senior Program Officer
PD
Patricia Davidson
Tufts Center For the Study of Drug Development, United States
PALADIN Consortium Director
Dedric Day
Eli Lilly and Company, United States
Senior Director- Strategic Talent Partnerships
Suranjan De
FDA, United States
Deputy Director, Regulatory Science, OSE, CDER
Andrew Deavin
GSK, Belgium
Senior Director, Regulatory Affairs
Chris Decker
CDISC, United States
President and CEO
SD
Sarah Demmon
Eli Lilly, United States
Vice President
Jenny Denney
Parexel , United States
EVP, Global Head Parexel FSP
SD
Sai Dharmarajan
Sarepta Therapeutics, United States
Director, Biostatistics
Victoria DiBiaso
Sanofi, France
Global Head, Patient Informed Development and Health Value Translation
Robert DiCicco
TransCelerate Biopharma Inc., United States
Vice President, Portfolio Management
AD
Abigail Dirks
Tufts Center for the Study of Drug Development, United States
Data Scientist
PD
Pamela Dobay
Biogen, Switzerland
Director
Bridget Doherty
Johnson & Johnson Innovative Medicine, United States
Director, Access and Policy Research
Victoria Dohnal
Johnson & Johnson, United States
Director, Global Regulatory Policy and Intelligence
Amanda Donovan
Takeda, United States
Director, Emerging Priorities & Innovation
CD
Carolyn Dorgan
Sutton's Creek, United States
Director, Technical Service
Megan Doyle
Eli Lilly & Company, United States
Associate Vice President, Assistant General Counsel - Diagnostics
Nancy Dreyer
Dreyer Strategies LLC, United States
Founder
RD
Ran Duan
Vertex Pharmaceuticals, United States
Director Biometrics
Kelly Dumais
Clario, United States
Director, eCOA Science and Consulting
Joseph Dustin
eClinical Consulting, United States
Founder and Managing Partner
RD
Roshan D'Souza
Roche Products Limited, United Kingdom
Head of Data Analytics and Operations, PDQ
Tamei Elliott
DIA, United States
Associate Director, Scientific Programs
NE
Noel Ellison
Trialwise, Inc., United States
SENIOR QUALITY ASSURANCE ASSOCIATE
KE
Khaled El Emam
University of Ottawa, Canada
Professor
Jennifer Emerson
Boehringer Ingelheim, Germany
Head Quality Analytics & Risk Management
Scott Evans
George Washington University Milken Institute of Public Health, United States
Professor and Founding Chair, Department of Biostatistics and...
Sarah Fairfield
AbbVie, United States
Associate Director, RA Device and Combination Products
Tony Fantana
Eli Lilly, United States
Sr. Dir
Jennifer Farmer
Friedreich's Ataxia Research Alliance (FARA), United States
Chief Executive Officer
Marwan Fathallah
DIA, United States
President & Chief Executive Officer
Jessica Federer
Angelini Ventures, United States
Board Member
YF
Yuli Felistia
National Brain Center, Mahar Mardjono Hospital, Indonesia
Head of Clinical Research Unit, Research Manager
Jay Ferro
Clario, United States
Chief Information, Technology and Product Officer
Lawrence Fine
Lawrence Fine, LLC, United States
Business Consultant
TF
Tetyana Fine
Astrazeneca, United States
Director, Global Regulatory Affairs
Kelly Fitzgerald
WCG , United States
Executive IRB Chair and Vice President of IBC Affairs
Ruby Ford
Tufts School of Medicine, United States
Research Analyst
DF
Debbi Fox
Health Canada, Canada
Compliance and Enforcement Specialist
JF
Jeffrey Francer
Eli Lilly and Company, United States
Vice President, Head of Global Regulatory Policy & Strategy
Julie Frearson
Charles River Laboratories, United States
Senior Vice President, Chief Scientific Officer
MF
Motoki Fujii
EPS Corporation, Japan
Senior Professional
DF
Denise Fulton
RAPS, United States
Vice President, Research & Content Strategy
MF
Michele Fusaroli
Uppsala Monitoring Centre, Sweden
JG
Jyothis George
Amgen, United Kingdom
Global Medical Vice President, Obesity and Related Conditions
Ellyn Getz
CSL Behring, United States
Director, R&D Partnerships
Kenneth Getz
Tufts University School of Medicine, United States
Tufts Center for the Study of Drug Development
Alicia Gilsenan
RTI Health Solutions, United States
Vice President, Epidemiology
Richard Gliklich
OM1, United States
Chief Executive Officer
SG
Sarah Golding
Therapeutics Goods Administration, Australia
Senior Medical Officer - Oncology and Malignant Haematology Clinical...
KG
Katharina Goldner
Bayer AG, Germany
Regional Regulatory Affairs Manager
Julien Nunes Goncalves
Cyntegrity, South Africa
Head of Growth
MP
Mercedes Perez Gonzalez
WHO, Switzerland
Technical officer
Robert (Mac) Gordon
Johnson & Johnosn Innovative Medicines, United States
Director, Biostatistics
RG
Ryan Gough
Woodberry Associates and PACH, United States
Partner, Senior Vice President, Public Affairs
HG
Heidi Grabenstatter
Critical Path Institute, United States
Scientific Director, RDCA-DAP
Cheryl Grandinetti
FDA, United States
Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
Courtney Granville
GO2 For Lung Cancer, United States
Chief Scientific Officer
HG
Hannah Graunke
Duke-Margolis Institute For Health Policy, United States
Senior Policy Analyst
Catherine Gregor
Florence Healthcare, United States
Chief Clinical Trial Officer
Anthony Gulotta
Leal Health, United States
Head of Sales and Strategic Partnerships
Tanvi Gupte
University of Maryland, United States
Student
Michelle Gyzen
IQVIA, United States
Sr. Director, Strategic Solutions - Regulatory Affairs & Drug...
Tarek Hammad
Takeda, United States
Vice President, Head of Medical Safety, Marketed Products &...
Gerrit Hamre
Duke-Margolis Institute For Health Policy (DMI), United States
Research Director
JH
Jackson Hanf
University of Southern California, United States
Student
Morgan Hanger
Clinical Trials Transformation Initiative (CTTI), United States
Executive Director
Magdalena Harrington
Pfizer, United States
Senior Director, Patient-Centered Outcomes Assessment (PCOA) Team Lead
FH
Fadhilah Hasbullah
National Pharmaceutical Regulatory Agency (NPRA) Malaysia, Malaysia
GCP Inspector
SH
Sema Hashemi
FDA, United States
Senior International Policy Advisor, OGPS, OC
Lani Hashimoto
Hashimoto Consulting Services, United States
Consultant, Patient Experience
Kristin Hatcher
Global Liver Institute/Alpha One Patient, United States
Director of Pediatric and Rare Disease/ Alpha One Lived Experience...
Melissa Heidelberg
Takeda, United States
Director, Global Bioethics and Technology Ethics Lead
Rachele Hendricks-Sturrup
Duke-Robert J. Margolis, MD, Institute For Health Policy, United States
Research Director, Real-World Evidence
NH
Nicole Herk
Medtronic, United States
Analytics Director
MP
Melissa Pauline Herman
Lundbeck A/S, Denmark
Senior Specialist, Patient Insights
Adrian Hernandez
Duke Clinical Research Institute , United States
Professor of Medicine; Executive Director
CH
Christopher Herrick
Mass General Brigham (MGB), United States
VP of Research Systems and Technology
AH
Amber Hill
R.grid, United Kingdom
Founder & CEO
HH
Hideki Hiraoka
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer
MH
Michal Hirsh-Vexberg
Israel Ministry of Health, Israel
Head of the Pharmaceuticals Registration Department, Medical...
Peter Hjelmstrom
Uppsala Monitoring Centre, Sweden
Director/CEO
Martin Hodosi
Kearney, United Kingdom
Partner, Healthcare and Life Sciences Practices
EH
Eimy Honda
University of São Paulo - USP, Brazil
Cindy Hoots
AstraZeneca, United States
Chief Digital Officer and Chief Information Officer
Paula Horowitz
AbbVie, United States
Program Manager, QA, GCP Software Validation
Ryan Hoshi
AbbVie, United States
Director, Regulatory Policy and Intelligence
PH
Philip Hougaard
Lundbeck A/S, Denmark
Vice President, Biostatistics and Data Science
Brett Howard
USP, United States
Senior Director, US Regulatory Policy
1
2
3
Share Modal
Share this link via
Or copy link
Copy
